Health ZhiGu Announces Shenzhen Landing to Focus on Precision Medicine, Healthcare Big Data, and AI Enterprises

From the Wuhan East Lake New Technology Pioneer Center in 1987 to the proliferation of industrial parks and mass innovation spaces, business incubators have continuously enriched their connotations. Their service offerings have evolved from initially providing only physical space to a comprehensive “space + resources + services” model. With over 30 years of development, the evolution of China’s business incubators mirrors the history of entrepreneurship in the country.

In the face of a complex and ever-changing entrepreneurial landscape, how can an “idea” be transformed into a product or service? How can entrepreneurs attract investors, secure marketing resources, and turn promising business concepts into reality? What kind of “incubation” do innovative enterprises need to help them grow from tiny seeds into towering trees?

Among numerous vivid incubator cases, Health Valley, backed by core industrial resources such as Tianyi Group, Meinian Onehealth, and Zhongwei Fund, is highly representative. Since 2014, Health Valley has established its presence in multiple cities across China. By introducing and serving over a thousand medical innovation enterprises, it has become the leading full-industry-chain incubation platform for healthcare and medicine in China.

With the latest Shenzhen industrial park of Health Intelligence Valley now established, VCBeat (WeChat ID: vcbeat) interviewed Wang Xiaojun, Vice President of Tianyi Group, CEO of Health Intelligence Valley, and Dean of the Zhongguancun Meinian Health Industry Research Institute. He shared his insights on startup incubation and outlined the initiatives that Health Intelligence Valley has undertaken in recent years to incubate early-stage healthcare ventures.

Health Intelligence Valley was established in June 2014 and represents Tianyi Group’s strategic initiative in the field of healthcare startup incubation. To understand the strategic logic and resource integration advantages of Health Intelligence Valley, it should be viewed within the broader context of Tianyi Group’s overall layout in the healthcare industry. Founded in 1998, Tianyi Group is a leading Chinese industrial and investment group centered on healthcare. It owns China’s largest professional health checkup and medical services cluster, including two listed companies: Meinian Onehealth and Wandong Medical.

After years of development, Tianyi Group has established a closed-loop healthcare ecosystem encompassing “health checkups–services–data,” creating a mature acceleration system for healthcare enterprises. It has now become the most powerful demand gateway and the most open supply platform in China’s health industry. Additionally, Zhongwei Fund, under Tianyi, is the most operationally mature healthcare industry fund in China. Since 2004, it has successfully invested in more than 20 companies that have gone public via IPOs, with the total market capitalization of its portfolio companies within the ecosystem exceeding RMB 100 billion.

On one hand, it leverages the resource aggregation advantages of Tianyi Group, Meinian Onehealth, and Zhongwei Fund; on the other, it taps into the innovative vitality of the medical industry driven by favorable policies for “mass entrepreneurship and innovation” and the development of the broader health sector. “The Health Intelligence Valley project should be understood within the broader policy context, such as ‘Healthy China 2030’ and initiatives encouraging private capital to enter healthcare services. Aligning with these policies, we aim to build an industrially incubating platform characterized by model innovation, serving entrepreneurs and fostering a conducive environment for medical innovation and startups,” said Wang Xiaojun.

The model innovation mentioned by Wang Xiaojun refers to the unique “concierge-style” service model of Health Intelligence Valley, which includes physical office spaces, supporting facilities, entrepreneurship training, investment resource matchmaking, and international resource connectivity.

Health Intelligence Valley “Concierge-Style” Service System(Image provided by the company)

Under this service model, Health Intelligence Valley has quickly distinguished itself among numerous industry incubators, becoming the leading industrial incubation platform for China’s healthcare sector. To date, it has established nine Health Intelligence Valley locations in the core areas of major cities including Beijing, Shanghai, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, and Ningbo, with a total floor area exceeding 300,000 square meters. It maintains an office in Silicon Valley, USA, has entered into strategic partnerships with innovative platforms such as Israel’s Rainbow and the US-based Rock Health, and is poised to expand into Xiamen, Fuzhou, Tianjin, Suzhou, and other cities.

Beijing Health Intelligence Valley (Photo provided by the company)

Shanghai Health Intelligence Valley (Photo provided by the enterprise)

The logic of Health Intelligence Valley operating as an industrial incubator through resource integration has comparable international benchmarks, such as WeWork and Rock Health. As a leading representative of co-working spaces, WeWork has expanded to 21 countries, covering more than 72 cities and 242 locations, with over 210,000 members. Rock Health, a typical healthcare incubator, provides medical startup teams with resources including office space, mentorship, and seed funding, while collaborating with healthcare institutions to facilitate the commercialization of startups’ products and services.

Health Intelligence Valley is akin to a hybrid of WeWork and Rock Health, providing enterprises with physical office space for lease while also investing in promising projects within its ecosystem and offering services to integrate and connect industrial resources. Currently, WeWork’s valuation has exceeded $20 billion, and Rock Health stands as the most sought-after industry incubator in the healthcare sector. From this perspective, Health Intelligence Valley holds substantial potential for future growth.

“Health Intelligence Valley uses physical space as a carrier to provide valuable full-industry-chain services for innovative enterprises, creating an industrial-agglomeration-oriented co-working space, with the aim of becoming the WeWork of China’s healthcare industry,” said Wang Xiaojun.

For the enterprises it serves, Health Intelligence Valley focuses on two main pillars: “medical services + technological innovation.” Technology-driven enterprises include those in fields such as genetic testing and artificial intelligence; medical service-driven enterprises encompass high-end health checkup centers, healthcare media outlets, dental care providers, and medical aesthetics companies.

From the list of incubated enterprises at Health Intelligence Valley, we see numerous star companies in the healthcare and medical sector, including Anhan Medical, Meiyin Genetics, and Baihui Weikang.

Anhan Medical, founded in 2009, is the world’s first company to successfully develop and commercialize a magnetically controlled capsule gastroscopy system through independent R&D, and it has consistently attracted strong interest from the capital market in recent years. Zhongwei Fund initiated cooperation negotiations in 2015 and invested in Anhan Medical in early 2016; subsequently, the company joined Health Intelligence Valley, which provided it with ongoing incubation support. Meinian Onehealth Healthcare Centers became a key channel for the widespread deployment of its products.

Anhan Medical received tens of millions of dollars in investment from SoftBank in February 2017. On August 15 of the same year, it entered into a strategic partnership with Dazhong Investment, Tongsheng Venture Capital, SoftBank China, Advantage Capital, Qiansheng Investment, and Houxin Health Investment. These six investment firms jointly invested $100 million to support Anhan Medical’s market expansion and subsequent R&D efforts. In March 2018, Anhan Medical was included in the “Unicorn” list jointly released by Great Wall Strategic Consulting and the Torch Center of the Ministry of Science and Technology, with an estimated valuation of approximately $1 billion.

According to Xinhua News Agency, on the afternoon of April 11, 2018, after concluding his activities at the Boao Forum for Asia Annual Conference 2018, Xi Jinping visited the Planning Exhibition Hall of the Boao Lecheng International Medical Tourism Pilot Zone. Standing before a row of advanced medical devices, General Secretary Xi listened to introductions by academicians while examining each item individually. He picked up a domestically produced magnetically controlled capsule gastroscope robot, no larger than a finger, and inquired in detail about its research, development, and application. This capsule gastroscope robot is a product of Anhan Medical.

Founded in 2016, Meiyin Gene has established a high-standard laboratory platform in compliance with medical laboratory requirements. Equipped with high-throughput sequencing and bioinformatics analysis platforms, the company leverages its proprietary patented technologies to reduce testing costs and promote the widespread adoption of genetic testing among the general public. Its marketed products include “Meiyin An” susceptibility gene testing, early screening for colorectal cancer, personal genome testing, and sports nutrition gene testing. Currently, Meiyin Gene has established collaborative partnerships with numerous health checkup chains and Grade-A tertiary hospitals.

Beijing Baihui Weikang Technology Co., Ltd. was established in 2010. Leveraging 18 years of technological accumulation, 15 years of clinical exploration, over 20,000 clinical surgeries, and six product iterations, the company independently developed and launched the next-generation Remebot Neurosurgical Surgical Robot in 2015. Equipped with a multi-functional operating platform, the system supports procedures such as biopsy, aspiration, ablation, transplantation, and radiotherapy, and is applicable to nearly 100 types of neurosurgical conditions across 12 categories. Recently, the Remebot Neurosurgical Surgical Robot officially passed the Class III medical device review by the China Food and Drug Administration (CFDA), becoming the first neurosurgical surgical robot to receive formal approval in China.

In addition to the aforementioned companies, numerous other enterprises have settled in Health Intelligence Valley and achieved sustained development.

Latest Financing Updates for Selected Companies Based in Health Intelligence Valley

Shenzhen Health Intelligence Valley (Photo provided by the enterprise)

“Focusing on the two main threads of translating scientific and technological achievements into practical applications and innovating healthcare service models, we have continuously incubated innovative enterprises, achieved notable results, and gained recognition from the industry. In the next step, we will prioritize breakthroughs in ‘speed’ and ‘quality,’ continually enriching the industrial incubation offerings of Health Intelligence Valley to help more innovative medical companies grow and thrive, thereby building the largest industrial aggregation platform in China,” Wang Xiaojun told VCBeat.Health Intelligence Valley will establish 30–50 locations over the next two to three years, expanding its coverage to more cities. For its next destination, Health Intelligence Valley has chosen Yantian, Shenzhen.

The choice of Shenzhen is closely tied to its local industrial endowments, accumulated industrial base, strategic geographic advantages, and policy guidance. Data show that by the end of 2016, the scale of Shenzhen’s biotechnology and life health industry had exceeded RMB 200 billion. As one of China’s first national-level bio-industry bases, Shenzhen has gathered a cluster of outstanding innovative enterprises such as BGI, Beike Biotechnology, Mindray, and Hepalink, demonstrating robust industrial innovation capabilities.

The establishment of Shenzhen Health Intelligence Valley is the result of a collaboration between Health Intelligence Valley, the Yantian District Government, and the prominent local enterprise Dabaihui Industrial Group, driven by “multi-engine propulsion and complementary resources.”

Tianyi Group Holds Talks with Shenzhen Yantian District Government and Dabaihui Group (Photo Provided by the Company)

Yantian Health Intelligence Valley is located within the Shenzhen Dabaihui Life and Health Industrial Park, adjacent to the Shenzhen International Biovalley. With a planned total construction area of nearly 50,000 square meters, it boasts unique locational and resource advantages.

Enterprises settling in Yantian Health Intelligence Valley will receive extensive support from the Yantian District Government, including rent subsidies, talent-assured housing, innovation and entrepreneurship funds, fiscal and tax incentives, and patent subsidies. Meanwhile, Yantian Health Intelligence Valley will collaborate with the Yantian District Government Guidance Fund and Dabaihui Industrial Group to jointly establish the “Zhonghui Fund,” with an investment scale of RMB 2 billion. This fund will make targeted investments in financial leasing companies, factoring companies, medical equipment import and export firms, and incubated enterprises within Yantian Health Intelligence Valley, thereby facilitating their rapid growth.

Nighttime Rendering of Shenzhen Health Intelligence Valley (Image Provided by the Company)

Following the establishment of the Yantian Health Intelligence Valley, the focus will primarily be on incubating enterprises in the fields of genomic life sciences, medical artificial intelligence, and big data. Wang Xiaojun stated, “Shenzhen ranks first globally in next-generation sequencing capabilities and is home to China’s only National GeneBank. It has a solid foundation for the development of stem cell and tumor immunocyte therapies, as well as gene therapy, with certain areas leading the nation. Furthermore, Meinian Onehealth has generated a vast amount of health examination data, which serves as the optimal ‘raw material’ for health big data. Since data is the most critical element in developing medical AI, this data source provides favorable conditions for advancing medical artificial intelligence.”

In the healthcare and wellness sector, Health Intelligence Valley has become a steadfast companion for medical entrepreneurs’ sustained growth, leveraging its unique resource aggregation advantages and “concierge-style” service model. It has ushered in a “new era” for medical startup incubation. Looking ahead, Health Intelligence Valley is expected to gradually replicate its industry incubation model across China, emerging as a powerful driver of healthcare innovation nationwide.

Shenzhen Health Intelligence Valley is launching a nationwide recruitment campaign, with parks established in the core areas of Beijing, Shanghai, Hangzhou, Chongqing, Chengdu, Wuhan, Ningbo, and other cities. If you are interested in exploring collaboration or tenancy opportunities,Please click to enterRegistration Channel。